On Monday, Hookipa Pharma Inc (NASDAQ: HOOK) was -3.37% down from the session before settling in for the closing price of $0.79. A 52-week range for HOOK has been $0.41 – $2.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 26.65% over the past five years. When this article was written, the company’s average yearly earnings per share was at 58.43%. With a float of $70.37 million, this company’s outstanding shares have now reached $96.55 million.
Let’s look at the performance matrix of the company that is accounted for 151 employees.
Hookipa Pharma Inc (HOOK) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Hookipa Pharma Inc stocks. The insider ownership of Hookipa Pharma Inc is 28.89%, while institutional ownership is 35.31%. The most recent insider transaction that took place on Aug 21 ’23, was worth 5,075. In this transaction Chief Financial Officer of this company bought 7,000 shares at a rate of $0.72, taking the stock ownership to the 43,092 shares. Before that another transaction happened on Aug 16 ’23, when Company’s Chief Financial Officer bought 8,000 for $0.71, making the entire transaction worth $5,712. This insider now owns 36,092 shares in total.
Hookipa Pharma Inc (HOOK) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.76 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.43% per share during the next fiscal year.
Hookipa Pharma Inc (NASDAQ: HOOK) Trading Performance Indicators
You can see what Hookipa Pharma Inc (HOOK) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Hookipa Pharma Inc (HOOK)
Hookipa Pharma Inc (NASDAQ: HOOK) saw its 5-day average volume 0.66 million, a positive change from its year-to-date volume of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 40.29%. Additionally, its Average True Range was 0.07.
During the past 100 days, Hookipa Pharma Inc’s (HOOK) raw stochastic average was set at 46.20%, which indicates a significant increase from 29.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.08% in the past 14 days, which was lower than the 103.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7256, while its 200-day Moving Average is $0.6734. Nevertheless, the first resistance level for the watch stands at $0.8633 in the near term. At $0.9667, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.0333. If the price goes on to break the first support level at $0.6933, it is likely to go to the next support level at $0.6267. The third support level lies at $0.5233 if the price breaches the second support level.
Hookipa Pharma Inc (NASDAQ: HOOK) Key Stats
There are 98,950K outstanding shares of the company, which has a market capitalization of 75.20 million. As of now, sales total 20,130 K while income totals -81,580 K. Its latest quarter income was 7,410 K while its last quarter net income were -24,820 K.
